Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and the like has, predictably, returned. As always, we are coping by quaffing cups of stimulation. Our choice today is cherry chocolate decadence and, of course, you are invited to join us. Remember, no prescription is so required. And so, on to another busy day. On that note, here are some tidbits. We hope your journey goes well today and, by all means, do keep in touch …

Department of Health and Human Services Secretary Alex Azar is scheduled to give a speech on Monday afternoon to address drug pricing reforms and, in particular, is expected to announce the Trump administration will require drug makers to disclose list prices in consumer ads, Politico writes. The idea has generated controversy and the pharmaceutical industry trade group, meanwhile, plans to announce its own plans for consumer ads on Monday morning.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy